Description
What is ANA – IFA?
Anti nuclear antibody- IFA test refers to antinuclear antibody (ANA) test through indirect fluorescent antibody (IFA) method to detect the presence of ANA in blood. ANAs are auto antibodies that attack body’s healthy cells and cause damage to the joints, skin, muscles, and other body parts. This test is suggested to people at risk or having autoimmune disorders such as rheumatoid arthritis, autoimmune hepatitis, scleroderma and systemic lupus erythematosus (SLE).
Most people have a minor percentage of ANA in their blood; however elevated ANA levels can be the sign of an autoimmune disease.
Why is ANA – IFA done?
- To determine the presence of an autoimmune disease like Systemic Lupus Erythematosus (SLE)
- To evaluate the possible presence of autoimmune Connective Tissue Disorders (CTDs) other than SLE such as Polymyositis, Scleroderma, Sjögren’s syndrome etc.
What does ANA – IFA Measure?
The Antinuclear Antibody (ANA) Test measures the amount and pattern of antinuclear antibodies in the blood. The immune system of the body is responsible for differentiating between the body’s own cells and foreign cells, like pathogens. Once the foreign cells are identified, they are then targeted and destroyed. In autoimmune disorders, the immune system of the body is unable to recognize certain cells as the body’s own cells and starts an immune response against them which results in their destruction. The recognition of ‘self’ and ‘non-self’ cells is mediated by certain proteins present on the surface of cells or inside them. When the immune system identifies a cell as foreign or ‘non-self’, it produces antibodies against these cells to destroy them. Antibodies produced in an autoimmune disease are called autoantibodies.
Antinuclear antibodies (ANA) are autoantibodies that are produced against protein markers present in the nucleus of certain cells of the body. They are produced in a number of autoimmune diseases but are most commonly produced in Systemic Lupus Erythematosus (SLE).
The Antinuclear Antibody Test can be performed either by Immunoassay method or Indirect Fluorescent Antibody (IFA) method to detect ANA in blood. Both these tests may be used by some laboratories together: the Immunoassay method screens for the presence of antinuclear antibodies, and IFA method subsequently confirms the positive or equivocal Immunoassay results.
Interpreting ANA – IFA results
Interpretations
The appearance of fluorescence is a positive result and indicates the presence of antinuclear antibodies.
The absence of fluorescence is a negative result and indicates the absence of antinuclear antibodies.
Positive results of IFA are expressed in two parts: as titers which are ratios that represent the highest dilution of the blood sample at which antinuclear antibodies were visible, and as the fluorescent pattern seen. Titer value indicates the amount of antinuclear antibodies in the blood, while the pattern of fluorescence indicates different autoimmune diseases.
Some common fluorescence patterns and autoimmune conditions associated with them include:
| FLUORESCENCE PATTERN | ASSOCIATED CONDITIONS |
| Homogenous or diffuse | SLE, drug-induced lupus, and mixed connective tissue disease |
| Nucleolar | Scleroderma or Polymyositis |
| Speckled | SLE, Sjögren syndrome, Scleroderma, Polymyositis, Rheumatoid Arthritis, and mixed connective tissue disease |
| Centromere or peripheral | Scleroderma and CREST Syndrome (Calcinosis, Raynaud syndrome, Esophageal dysmotility, Sclerodactyly, Telangiectasia) |
Additional information
| Provider | Healths First, Lal Pathlab, Medcis Pathlab |
|---|
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.